Open AccessNonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C
Author(s) -
Jihane N. Benhammou,
Andrew M. Moon,
Joseph R. Pisegna,
Feng Su,
Philip Vutien,
Cynthia A. Moylan,
George N. Ioannou
Publication year - 2020
Publication title -
digestive diseases and sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 124
eISSN - 1573-2568
pISSN - 0163-2116
DOI - 10.1007/s10620-020-06457-2
Subject(s) - nonalcoholic fatty liver disease , hepatology , medicine , gastroenterology , transplant surgery , antiviral treatment , liver disease , hepatitis c , hepatitis , affect (linguistics) , fatty liver , disease , chronic hepatitis , immunology , virus , linguistics , philosophy
In hepatitis C (HCV) patients, obesity and/or diabetes may increase the risk of liver-related outcomes. We aimed to determine whether diabetes and/or obesity are associated with adverse outcomes in direct-acting antiviral (DAA)-treated HCV patients.